Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Characterization of CNVs in a Large Cohort of VWD Patients Reveals Relationship between Disrupted Regions, Clinical Variables and Disease Type

Brooke Sadler, Pamela A Christopherson, Crystal L Perry, Daniel B. Bellissimo, Sandra L Haberichter, Gabe Haller, Lilian Antunes, Veronica H Flood, Jorge Di Paola, Robert R Montgomery, The Zimmerman Program Investigators

Blood (2022) 140 (Supplement 1): 2753–2754.

https://doi.org/10.1182/blood-2022-163383

Published: 2022

Journal Articles

The Von Willebrand Disease Aging and Bleeding Correlation (VWD ABC) Study

Craig D. Seaman, Margaret V. Ragni, Peter A. Kouides, Eric H. Kraut, Rajiv K. Pruthi, Leslie J. Raffini, Jonathan C. Roberts, Annette von Drygalski, Daniel B. Bellissimo, Maria M Brooks

Blood (2021) 138 (Supplement 1): 1044.

https://doi.org/10.1182/blood-2021-152755

Published: 2021

Journal Articles

F5 Sequence Variant Identified in 7 Patients Evaluated for Hypercoagulable State with a Factor V (FV) HR2 Assay

Margaret M. Leech, BA, Daniel B. Bellissimo, PhD, John A. Uhrmacher, PhD, Sriya W. Gunawardena, MD, Michael J. Meyer, BA, MS, Franklin A. Bontempo, MD

Blood (2018) 132 (Supplement 1): 5053.

https://doi.org/10.1182/blood-2018-99-114203

Published: 2018

Journal Articles

Genotype-Phenotype Relationship and the Role of Alloantibodies in Type 3 VWD in the Zimmerman Program

Pamela A Christopherson, Crystal L Perry, Daniel B. Bellissimo, PhD, Veronica H Flood, MD, Joan Cox Gill, MD, Sandra L Haberichter, PhD, Robert R. Montgomery, MD, Zimmerman Program Investigators

Blood (2017) 130 (Supplement 1): 19.

https://doi.org/10.1182/blood.V130.Suppl_1.19.19

Published: 2017

Journal Articles

Identification of Copy Number Variants in Type 1 and Type 3 VWD by aCGH in the Zimmerman Program

Pamela A Christopherson, Rupa A Udani, PhD, Crystal Perry, BS, Daniel B Bellissimo, PhD, Sandra L Haberichter, PhD, Veronica H Flood, MD, Kenneth D Friedman, MD, Joan Cox Gill, MD, Robert R. Montgomery, MD, Zimmerman Program Investigators

Blood (2016) 128 (22): 872.

https://doi.org/10.1182/blood.V128.22.872.872

Published: 2016

Journal Articles

A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders

Ilenia Simeoni, Jonathan C. Stephens, Fengyuan Hu, Sri V. V. Deevi, Karyn Megy, Tadbir K. Bariana, Claire Lentaigne, Sol Schulman, Suthesh Sivapalaratnam, Minka J. A. Vries, Sarah K. Westbury, Daniel Greene, Sofia Papadia, Marie-Christine Alessi, Antony P. Attwood, Matthias Ballmaier, Gareth Baynam, Emilse Bermejo, Marta Bertoli, Paul F. Bray, Loredana Bury, Marco Cattaneo, Peter Collins, Louise C. Daugherty, Rémi Favier, Deborah L. French, Bruce Furie, Michael Gattens, Manuela Germeshausen, Cedric Ghevaert, Anne C. Goodeve, Jose A. Guerrero, Daniel J. Hampshire, Daniel P. Hart, Johan W. M. Heemskerk, Yvonne M. C. Henskens, Marian Hill, Nancy Hogg, Jennifer D. Jolley, Walter H. Kahr, Anne M. Kelly, Ron Kerr, Myrto Kostadima, Shinji Kunishima, Michele P. Lambert, Ri Liesner, José A. López, Rutendo P. Mapeta, Mary Mathias, Carolyn M. Millar, Amit Nathwani, Marguerite Neerman-Arbez, Alan T. Nurden, Paquita Nurden, Maha Othman, Kathelijne Peerlinck, David J. Perry, Pawan Poudel, Pieter Reitsma, Matthew T. Rondina, Peter A. Smethurst, William Stevenson, Artur Szkotak, Salih Tuna, Christel van Geet, Deborah Whitehorn, David A. Wilcox, Bin Zhang, Shoshana Revel-Vilk, Paolo Gresele, Daniel B. Bellissimo, Christopher J. Penkett, Michael A. Laffan, Andrew D. Mumford, Augusto Rendon, Keith Gomez, Kathleen Freson, Willem H. Ouwehand, Ernest Turro

Blood (2016) 127 (23): 2791–2803.

https://doi.org/10.1182/blood-2015-12-688267

Published: 2016

Includes: Supplemental data

Journal Articles

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States

Blood (2016) 127 (20): 2481–2488.

https://doi.org/10.1182/blood-2015-10-673681

Published: 2016

Includes: Supplemental data

Journal Articles

Domain Distribution of Type 1 VWD Sequence Variants and Impact on Clinical and Laboratory Phenotype in the Zimmerman Program

Pamela A Christopherson, Veronica H Flood, MD, Sandra L Haberichter, PhD, Daniel B Bellissimo, PhD, Kenneth D Friedman, MD, Joan Cox Gill, MD, Rupa A Udani, PhD, Robert R Montgomery, MD

Blood (2015) 126 (23): 758.

https://doi.org/10.1182/blood.V126.23.758.758

Published: 2015

Journal Articles

Crucial role for the VWF A1 domain in binding to type IV collagen

Veronica H. Flood, Abraham C. Schlauderaff, Sandra L. Haberichter, Tricia L. Slobodianuk, Paula M. Jacobi, Daniel B. Bellissimo, Pamela A. Christopherson, Kenneth D. Friedman, Joan Cox Gill, Raymond G. Hoffmann, Robert R. Montgomery, the Zimmerman Program Investigators

Blood (2015) 125 (14): 2297–2304.

https://doi.org/10.1182/blood-2014-11-610824

Published: 2015

Journal Articles

Spectrum of Type 2 Von Willebrand Disease in the Zimmerman Program

Veronica H Flood, MD, Pamela A Christopherson, Daniel B Bellissimo, PhD, Joan Cox Gill, MD, Sandra L Haberichter, PhD, Kenneth D Friedman, MD, Rupa A Udani, PhD, Jonathan C Roberts, Robert R Montgomery, MD, The Zimmerman Program Investigators

Blood (2014) 124 (21): 472.

https://doi.org/10.1182/blood.V124.21.472.472

Published: 2014

Journal Articles

Phenotypic Variability in Carriers of Von Willebrand Factor Truncating Sequence Variants in the Zimmerman Program

Daniel B Bellissimo, PhD, Rupa A Udani, PhD, Pamela A. Christopherson, Kenneth D. Friedman, MD, Joan Cox Gill, MD, Sandra L. Haberichter, PhD, Robert R Montgomery, MD, Veronica H. Flood, MD

Blood (2014) 124 (21): 2833.

https://doi.org/10.1182/blood.V124.21.2833.2833

Published: 2014

Journal Articles

Regions on Chromosomes 1 and 14 Are Associated with VWF:Ag Levels in African Americans Using Mapping By Admixture Linkage Disequilibrium

Andrew D Paterson, MD, Nicole M Roslin, Pamela A. Christopherson, Daniel B Bellissimo, PhD, Veronica H Flood, MD, Sandra L. Haberichter, PhD, Robert R Montgomery, MD, Zimmerman Program Investigators

Blood (2014) 124 (21): 2840.

https://doi.org/10.1182/blood.V124.21.2840.2840

Published: 2014

Journal Articles

The Management of Bleeding Risk in Von Willebrand Disease: Should Blood Group O Make a Difference?

Joan Cox Gill, MD, Veronica H Flood, MD, Pamela A Christopherson, Daniel B Bellissimo, PhD, Kenneth D Friedman, MD, Sandra L Haberichter, PhD, Rupa A Udani, PhD, Robert R. Montgomery, MD, The Zimmerman Program Investigators

Blood (2014) 124 (21): 2829.

https://doi.org/10.1182/blood.V124.21.2829.2829

Published: 2014

Journal Articles

Characterization and Expression of an In-Frame Exon 33-34 Deletion Causing Type 1 VWD

Ashley Cartwright, PhD, Pamela A Christopherson, Crystal L. Perry, Sandra L Haberichter, PhD, Daniel Hampshire, PhD, Ian R. Peake, PhD, Anne Goodeve, PhD, Robert R Montgomery, MD, Daniel B. Bellissimo, the Zimmerman Program Investigators

Blood (2014) 124 (21): 1525.

https://doi.org/10.1182/blood.V124.21.1525.1525

Published: 2014

Journal Articles

Assessment of Erythroid Chimerism in Sickle Cell Patients Undergoing HSCT By Digital Droplet PCR

Lihui Yin, PhD, Rupa A Udani, PhD, Mary Parlow, Daniel B Bellissimo, PhD, Joel A Brochstein, MD FAAP

Blood (2014) 124 (21): 563.

https://doi.org/10.1182/blood.V124.21.563.563

Published: 2014

Journal Articles

Critical Importance Of VWF Propeptide (VWFpp) In The Diagnosis Of Type 1 Von Willebrand Disease (VWD)

Sandra L. Haberichter, Pamela A. Christopherson, Veronica H. Flood, MD, Joan Cox Gill, MD, Daniel B. Bellissimo, Kenneth D Friedman, Robert R. Montgomery, MD, The Zimmerman Program Investigators

Blood (2013) 122 (21): 331.

https://doi.org/10.1182/blood.V122.21.331.331

Published: 2013

Journal Articles

The Complete Type I VWD Cohort Of The Zimmerman Program For The Molecular and Clinical Biology Of VWD - Phenotypic Assignment, Mutation Frequency, and Bleeding Assessment

Robert R. Montgomery, MD, Pamela Christopherson, Daniel B. Bellissimo, Joan Cox Gill, Sandra L. Haberichter, Veronica H. Flood, MD, David Lillicrap, Anne C. Goodeve, Kenneth D Friedman, Thomas C. Abshire, Amy D. Shapiro, Margaret V. Ragni, Steven R. Lentz, Cindy A. Leissinger, Amy L. Dunn, Jeanne Lusher, Deborah Brown

Blood (2013) 122 (21): 332.

https://doi.org/10.1182/blood.V122.21.332.332

Published: 2013

Journal Articles

Binding Of VWF To Type IV Collagen: An Additional Collagen Binding Mechanism Beyond Types I, III, and VI Collagen?

Veronica H. Flood, MD, Joan Cox Gill, Sandra L. Haberichter, Daniel B Bellissimo, PhD, Pamela A Christopherson, Kenneth D Friedman, MD, Robert R. Montgomery, MD, The Zimmerman Program Investigators

Blood (2013) 122 (21): 333.

https://doi.org/10.1182/blood.V122.21.333.333

Published: 2013

Journal Articles

Novel Germline CEBPA Sequence Variations in Familial AML and Cytogenetically Normal AML.

Rupa A. Udani, PhD, Mary Parlow, Lihui Yin, PhD, Daniel B. Bellissimo, PhD

Blood (2012) 120 (21): 2566.

https://doi.org/10.1182/blood.V120.21.2566.2566

Published: 2012

Journal Articles

VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population

Daniel B. Bellissimo, Pamela A. Christopherson, Veronica H. Flood, Joan Cox Gill, Kenneth D. Friedman, Sandra L. Haberichter, Amy D. Shapiro, Thomas C. Abshire, Cindy Leissinger, W. Keith Hoots, Jeanne M. Lusher, Margaret V. Ragni, Robert R. Montgomery

Blood (2012) 119 (9): 2135–2140.

https://doi.org/10.1182/blood-2011-10-384610

Published: 2012

NARROW

Characterization of CNVs in a Large Cohort of VWD Patients Reveals Relationship between Disrupted Regions, Clinical Variables and Disease Type

The Von Willebrand Disease Aging and Bleeding Correlation (VWD ABC) Study

F5 Sequence Variant Identified in 7 Patients Evaluated for Hypercoagulable State with a Factor V (FV) HR2 Assay

Genotype-Phenotype Relationship and the Role of Alloantibodies in Type 3 VWD in the Zimmerman Program

Identification of Copy Number Variants in Type 1 and Type 3 VWD by aCGH in the Zimmerman Program

A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders

Clinical and laboratory variability in a cohort of patients diagnosed with type 1 VWD in the United States

Domain Distribution of Type 1 VWD Sequence Variants and Impact on Clinical and Laboratory Phenotype in the Zimmerman Program

Crucial role for the VWF A1 domain in binding to type IV collagen

Spectrum of Type 2 Von Willebrand Disease in the Zimmerman Program

Phenotypic Variability in Carriers of Von Willebrand Factor Truncating Sequence Variants in the Zimmerman Program

Regions on Chromosomes 1 and 14 Are Associated with VWF:Ag Levels in African Americans Using Mapping By Admixture Linkage Disequilibrium

The Management of Bleeding Risk in Von Willebrand Disease: Should Blood Group O Make a Difference?

Characterization and Expression of an In-Frame Exon 33-34 Deletion Causing Type 1 VWD

Assessment of Erythroid Chimerism in Sickle Cell Patients Undergoing HSCT By Digital Droplet PCR

Critical Importance Of VWF Propeptide (VWFpp) In The Diagnosis Of Type 1 Von Willebrand Disease (VWD)

The Complete Type I VWD Cohort Of The Zimmerman Program For The Molecular and Clinical Biology Of VWD - Phenotypic Assignment, Mutation Frequency, and Bleeding Assessment

Binding Of VWF To Type IV Collagen: An Additional Collagen Binding Mechanism Beyond Types I, III, and VI Collagen?

Novel Germline CEBPA Sequence Variations in Familial AML and Cytogenetically Normal AML.

VWF mutations and new sequence variations identified in healthy controls are more frequent in the African-American population

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only